Business Description
Eutilex Co Ltd
ISIN : KR7263050007
Share Class Description:
XKRX:263050: Ordinary SharesCompare
Compare
Traded in other countries / regions
263050.Korea IPO Date
2018-12-24Description
Eutilex Co Ltd is a Korean that operates in the anti-tumor immunotherapy market. The company develops anti-tumor T cell therapy and antibody therapeutics based on its immunotherapy technology. Its pipeline products include T Cell Therapy (4-1BB CTL), CAR-T, and Antibody.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.95 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -0.39 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1.46 | |||||
| Beneish M-Score | 26.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -64.2 | |||||
| 3-Year EBITDA Growth Rate | 11.7 | |||||
| 3-Year EPS without NRI Growth Rate | 8.6 | |||||
| 3-Year FCF Growth Rate | 8.3 | |||||
| 3-Year Book Growth Rate | -9.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.82 | |||||
| 9-Day RSI | 40.04 | |||||
| 14-Day RSI | 40.13 | |||||
| 6-1 Month Momentum % | 1.82 | |||||
| 12-1 Month Momentum % | -16.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.29 | |||||
| Quick Ratio | 2.23 | |||||
| Cash Ratio | 1.81 | |||||
| Days Inventory | 15.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.8 | |||||
| Shareholder Yield % | -1.13 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 15.97 | |||||
| Operating Margin % | -380.18 | |||||
| Net Margin % | -367.62 | |||||
| FCF Margin % | -341.66 | |||||
| ROE % | -44.7 | |||||
| ROA % | -35.29 | |||||
| ROIC % | -55.22 | |||||
| ROC (Joel Greenblatt) % | -81.54 | |||||
| ROCE % | -40.36 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.76 | |||||
| PB Ratio | 1.46 | |||||
| Price-to-Tangible-Book | 1.6 | |||||
| EV-to-EBIT | -2.61 | |||||
| EV-to-EBITDA | -3.11 | |||||
| EV-to-Revenue | 9.62 | |||||
| EV-to-FCF | -2.85 | |||||
| Price-to-Net-Current-Asset-Value | 18.17 | |||||
| Earnings Yield (Greenblatt) % | -38.27 | |||||
| FCF Yield % | -31.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eutilex Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 6,893.522 | ||
| EPS (TTM) (â‚©) | -689 | ||
| Beta | 1.43 | ||
| Volatility % | 80.74 | ||
| 14-Day RSI | 40.13 | ||
| 14-Day ATR (â‚©) | 121.569384 | ||
| 20-Day SMA (â‚©) | 2110.8 | ||
| 12-1 Month Momentum % | -16.1 | ||
| 52-Week Range (â‚©) | 1765 - 3700 | ||
| Shares Outstanding (Mil) | 36.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eutilex Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eutilex Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eutilex Co Ltd Frequently Asked Questions
What is Eutilex Co Ltd(XKRX:263050)'s stock price today?
The current price of XKRX:263050 is â‚©2015.00. The 52 week high of XKRX:263050 is â‚©3700.00 and 52 week low is â‚©1765.00.
When is next earnings date of Eutilex Co Ltd(XKRX:263050)?
The next earnings date of Eutilex Co Ltd(XKRX:263050) is .
Does Eutilex Co Ltd(XKRX:263050) pay dividends? If so, how much?
Eutilex Co Ltd(XKRX:263050) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers